Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Liu, Liqun ^a,b   Yu, Jingyi ^b,c   Li, Li ^c,d   Zhang, Bao ^b,c   Liu, Lingjuan ^a   Wu, Chun Hua ^b   Jong, Ambrose ^b   Mao, Ding An ^a   Huang, Sheng He ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; BUNGAROTOXIN RECEPTOR; GLYCOPROTEIN GP 120; METHAMPHETAMINE; METHYLLYCACONITINE; NICOTINE; PROTEIN S 100;

ALZHEIMER DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD BRAIN BARRIER; BRAIN; C57BL MOUSE; CELL AGING; CELL MOTION; CEREBROSPINAL FLUID; DRUG EFFECT; ENDOTHELIUM CELL; HL-60 CELL LINE; HUMAN; INJURIES; METABOLISM; MONOCYTE; PATHOLOGY; PROTEIN TRANSPORT; TIME FACTOR;

ACONITINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; BIOMARKERS; BLOOD-BRAIN BARRIER; BRAIN; CELL MOVEMENT; CELLULAR SENESCENCE; ENDOTHELIAL CELLS; HIV ENVELOPE PROTEIN GP120; HL-60 CELLS; HUMANS; METHAMPHETAMINE; MICE, INBRED C57BL; MONOCYTES; NICOTINE; PROTEIN TRANSPORT; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; S100 PROTEINS; TIME FACTORS;

EID: 85009209173     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40467     Document Type: Article

References (48)

1. Manda, K. R., Banerjee, A., Banks, W. A., & Ercal, N. Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells. Free Radic Biol Med 50, 801-810 (2011
2. Lamers, S. L., Gray, R. R., Salemi, M., Huysentruyt, L. C., & McGrath, M. S. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol 11, 31-37 (2011
3. Tavazzi, E., Morrison, D., Sullivan, P., Morgello, S., & Fischer, T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res 12, 97-110 (2014
4. Cardoso, S. W., et al. Aging with HIV: a practical review. Braz J Infect Dis 17, 464-479 (2013
5. Gates, T. M., & Cysique, L. A. The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review. CNS Drugs 30(1), 53-69 (2016
6. András, I. E., & Toborek, M. Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life 65, 43-49 (2013
7. An, S. F., et al. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56, 1262-1268 (1997
8. Banerjee, A., Zhang, X., Manda, K. R., Banks, W. A., & Ercal, N. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-Acetylcysteine amide. Free Radic Biol Med 48, 1388-1398 (2010
9. Ortega, M., & Ances, B. M. Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol 9, 483-491 (2014
10. Chi, F., et al. Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS One 6, e25016 (2011
11. Huang, S. H., et al. Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors. PLoS One 8, e62164 (2013
12. Zhang, B., et al. Alpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factors. BMC Infect Dis 15, 352 (2015
13. Oddo, S., et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci USA 102, 3046-3051 (2005
14. Deane, R., & Zlokovic, B. V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 4, 191-197 (2007
15. Rangachari, V., et al. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry 46, 12451-12462 (2007
16. Leclerc, E., Sturchler, E., & Vetter, S. W. The S100B/RAGE Axis in Alzheimer's Disease. Cardiovasc Psychiatry Neurol 2010, 539581 (2010
17. Stins, M. F., et al. Gp120 activates children's brain endothelial cells via CD4. J Neurovirol 7, 125-134 (2001
18. Ben, P., & Weinberg, R. A. The signals and pathways activating cellular senescence, Int J Biochem Cell Biol 37, 961-976 (2005
19. Schmitt, C. A. Cellular senescence and cancer treatment. Biochim Biophys Acta 1775, 5-20 (2007
20. Wang, H., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388 (2003
21. Egea, J., et al. Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochem Pharmacol 97, 463-472 (2015
22. Kalkman, H. O., & Feuerbach, D. Modulatory effects of a 7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol Life Sci 73, 2511-2530 (2016
23. Pinkaew, D., et al. Association of Neuroprotective Effect of Di-O-Demethylcurcumin on Aβ 25-35-Induced Neurotoxicity with Suppression of NF-? B and Activation of Nrf2. Neurotox Res 29, 80-91 (2016
24. Puzzo, D., et al. Picomolar amyloid- beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545 (2008
25. Selkoe, D. J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192, 106-113 (2008
26. Khan, M. B., et al. Nef exosomes isolated from the plasma of individuals with HIV-Associated dementia (HAD) can induce Aβ 1-42 secretion in SH-SY5Y neural cells. J Neurovirol 22, 179-190 (2016
27. Aksenov, M. Y., Aksenova, M. V., Mactutus, C. F., & Booze, R. M. HIV-1 protein- mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett 475, 174-178 (2010
28. Puzzo, D., Gulisano, W., Arancio, O., & Palmeri, A. The keystone of Alzheimer pathogenesis might be sought in Aβ physiology. Neuroscience 307, 26-36 (2015
29. Lfffler, T., Flunkert, S., Temmel, M., & Hutter-Paier, B. Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction. Front Neurosci 10, 232 (2016
30. Storck, S. E., et al. Endothelial LRP1 transports amyloid-β (1-42) across the blood-brain barrier. J Clin Invest 126, 123-136 (2016
31. Cho, S. M., et al. Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model. Sci Rep 4, 6777 (2014
32. Escubedo, E., Camarasa, J., Chipana, C., García-Ratés, S., & Pubill, D. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. Int Rev Neurobiol 88, 121-166 (2009
33. Costes, S., Gurlo, T., Rivera, J. F., & Butler, P. C. UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β -cells: evidence of interplay between the ubiquitin/proteasome system and autophagy. Autophagy 10, 1004-1014 (2014
34. Gong, B., & Leznik, E. The role of ubiquitin C-Terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect 20, 365-370 (2007
35. Oliveira, A. S., et al. BAG2 expression dictates a functional intracellular switch between the p38-dependent effects of nicotine on tau phosphorylation levels via the a 7 nicotinic receptor. Exp Neurol 275, 69-77 (2016
36. Angelo, M. F., et al. The proinflammatory RAGE/NF-? B pathway is involved in neuronal damage and reactive gliosis in a model of sleep apnea by intermittent hypoxia. PLoS One 9, e107901 (2014
37. Prasad, S., Sajja, R. K., Naik, P., & Cucullo, L. Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. J Pharmacovigil 2, 125 (2014
38. Ballester, L. Y., et al. Up-regulation of the neuronal nicotinic receptor a 7 by HIV glycoprotein 120: potential implications for HIVassociated neurocognitive disorder. J Biol Chem 287, 3079-3086 (2012
39. Tan S., et al. Peptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infection. FEBS Lett 588, 1515-1522 (2014
40. Chen J., et al. A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection. PLoS One 10, e0144522 (2015
41. Peng, Q. L., et al. Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections. Int J Neurosci 25, 1-9 (2016
42. Costantini, T. W., et al. CHRFAM7A, a human-specific and partially duplicated a 7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury. J Leukoc Biol 97, 247-57 (2015
43. Stins, M. F., Badger, J. L., & Kim, K. S. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathogenesis 30, 19-28 (2001
44. Mahajan, S. D., et al. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res 1203, 133-148 (2008
45. Chi, F., et al. Vimentin-mediated signaling is required for IbeA+ Escherichia coli K1 invasion of human brain microvascular endothelial cells. Biochem J 427, 79-90 (2010
46. Che, X., et al. Involvement of IbeA in meningitic Escherichia coli K1-induced polymorphonuclear leukocyte transmigration across brain endothelial cells. Brain Pathol 21, 389-404 (2011
47. Moreland, J. G., & Bailey, G. Neutrophil transendothelial migration in vitro to Streptococcus pneumoniae is pneumolysin dependent. Am J Physiol Lung Cell Mol Physiol 290, 833-840 (2006
48. Moreland, J. G., Bailey, G., Nauseef, W. M., & Weiss, J. P. Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J Immunol 172, 426-432 (2004